Driving Progress in Research, Care, and Community

  • About Us
    • Our Story & Goals
    • Team
    • 2026-2031 Strategic Plan
    • Financials
  • Parent Guide
    • Understanding CAMK2
    • CAMK2 Symptoms Overview
    • Family Resources
  • Research
    • CAMK2 Researchers
    • Scientific Resources
  • News/Events
    • Events
    • News
  • Donate
  • Contact Us

Below are the financial statements for the CAMK2 Therapeutics Network. We received our 501(c)(3) status in 2025, and once the 2025 tax documents are completed, we will post them here for full transparency.

2022 CAMK2 Financial Reports

2023 CAMK2 Financial Reports

Disclaimer: CAMK2 Therapeutics Network is not a medical provider or healthcare facility. It cannot diagnose, treat or recommend specific medical treatments. Patients must rely on individualized medical advice from qualified healthcare professionals before seeking any information related to their particular diagnosis or treatment of condition or disorder.

The CAMK2 Therapeutics Network is a charitable project of the San Francisco Study Center, a U.S. 501(c)(3) fiscal sponsor (EIN: 39-2150859). Donations to CAMK2 Therapeutics Network are fully tax-deductible for U.S. donors.

All trademarks, logos and service marks displayed on this website, including the CAMK2 logo, are the property of CAMK2 Therapeutics Network, or of the respective research and medical institutions included here for informational purposes.

© CAMK2 Therapeutics Network 2025. All rights reserved

The CAMK2 Therapeutics Network is a family-led, collaborative initiative improving lives of those with CAMK2 disorders through education, access to care, and accelerated treatments.

DONATE NOW

Follow us on Facebook

facebook logo png transparent background 17221797 PNG

CAMK2 Therapeutics Network

1330 California Ave

Palo Alto, CA  94306

EIN 39-2150859